|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 1.928 SEK | -2.72% |
|
-4.55% | -2.13% |
| 10-20 | Irlab research behind linepemat published in journal | FW |
| 10-20 | IRLAB Therapeutics AB Announces Publication Of Preclinical Research Underpinning Linepemat In Peer-Reviewed Journal | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- IRLAB A Stock
- Charts IRLAB Therapeutics AB
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
